UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes

Endocrinology (Philadelphia), 2001-06, Vol.142 (6), p.2702-2706

2001

Volltextzugriff (PDF)

The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers

European journal of clinical pharmacology, 1996, Vol.51 (3-4), p.303-308

1996

Volltextzugriff (PDF)

Comparative effects of fluoxetine and amitriptyline on cardiac function

British journal of clinical pharmacology, 1988-10, Vol.26 (4), p.399-402

1988

Volltextzugriff (PDF)

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist

European journal of cancer (1990), 1990, Vol.26 Suppl 1, p.S12

1990

Volltextzugriff (PDF)

Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation

Bone marrow transplantation (Basingstoke), 1991-06, Vol.7 (6), p.439-441

1991

Volltextzugriff (PDF)

The pharmacokinetics of pranlukast in healthy young and elderly subjects

International journal of clinical pharmacology and therapeutics, 1996-09, Vol.34 (9), p.375

1996

Volltextzugriff (PDF)

In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

Endocrinology (Philadelphia), 2003-06, Vol.144 (6), p.2404-2408

2003

Volltextzugriff (PDF)

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects

European journal of clinical pharmacology, 1994-03, Vol.46 (2), p.159

1994

Volltextzugriff (PDF)

The people's charter

The Health service journal, 1994-01, Vol.104 (5385), p.26

Upward, J

1994

Volltextzugriff (PDF)

Oral labetalol in the management of stable angina pectoris in normotensive patients

British Heart Journal, 1985-01, Vol.53 (1), p.53-57

1985

Volltextzugriff (PDF)

The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteers

European journal of clinical pharmacology, 1995-10, Vol.48 (6), p.519-520

1995

Volltextzugriff (PDF)

Class II antiarrhythmic agents

Pharmacology & therapeutics (Oxford), 1988, Vol.37 (1), p.81-109

1988

Volltextzugriff (PDF)

Increased diastolic blood pressure response to exercise testing when coronary artery disease is suspected. An indication of severity

British Heart Journal, 1985-06, Vol.53 (6), p.598-602

1985

Volltextzugriff (PDF)

Inhibition of proteasome activity by selected amino acids

Metabolism, clinical and experimental, 2003-07, Vol.52 (7), p.805-809

2003

Volltextzugriff (PDF)

BRL 43694: A Novel Antiemetic to Prevent Nausea and Vomiting Induced by Chemotherapy

JNCI : Journal of the National Cancer Institute, 1988-10, Vol.80 (16), p.1340-1341

1988

Volltextzugriff (PDF)

Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride

The American journal of cardiology, 1985-06, Vol.55 (13), p.1589-1595

1985

Volltextzugriff (PDF)

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.950-958

2001

Volltextzugriff (PDF)

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

Journal of clinical pharmacology, 2001-09, Vol.41 (9), p.950-958

2001

Volltextzugriff (PDF)

Early exercise testing and elective coronary artery bypass surgery after uncomplicated myocardial infarction. Effect on morbidity and mortality

British Heart Journal, 1984-10, Vol.52 (4), p.413-417

1984

Volltextzugriff (PDF)

The pharmacokinetics of doxazosin in patients with hypertension and renal impairment

British journal of clinical pharmacology, 1990-04, Vol.29 (4), p.417-422

1990

Volltextzugriff (PDF)

Early exercise testing and coronary angiography after uncomplicated myocardial infarction

British medical journal (Clinical research ed.), 1982-05, Vol.284 (6325), p.1293

1982

Volltextzugriff (PDF)

A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine

European heart journal, 1984-03, Vol.5 (3), p.247-252

1984

Volltextzugriff (PDF)

The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction

European journal of clinical pharmacology, 1983-01, Vol.25 (5), p.589-594

1983

Volltextzugriff (PDF)

Nouvelles anarchistes : La création littéraire dans le presse militante (1890-1946)

Vittorio Frigerio

2012

Volltextzugriff (PDF)

Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers

British journal of clinical pharmacology, 1997-09, Vol.44 (3), p.289-291

1997

Volltextzugriff (PDF)

1 – 25 von 78

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(61)
Mit Volltextzugriff
(67)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Insulin inhibits peroxisomal fatty acid oxidation in isolated rat hepatocytes

The single and multiple dose pharmacokinetics of pranlukast in healthy volunteers

Comparative effects of fluoxetine and amitriptyline on cardiac function

The clinical pharmacology of granisetron (BRL 43694), a novel specific 5-HT3 antagonist

Granisetron, a selective 5-HT3 receptor antagonist, for the prevention of radiation induced emesis during total body irradiation

The pharmacokinetics of pranlukast in healthy young and elderly subjects

In Vitro Inhibition of Insulin-Degrading Enzyme by Long-Chain Fatty Acids and Their Coenzyme A Thioesters

Pharmacokinetics and tolerability of ascending intravenous doses of granisetron, a novel 5-HT3 antagonist, in healthy human subjects

The people's charter

Oral labetalol in the management of stable angina pectoris in normotensive patients

The pharmacokinetics of granisetron, a 5-HT3 antagonist in healthy young and elderly volunteers

Class II antiarrhythmic agents

Increased diastolic blood pressure response to exercise testing when coronary artery disease is suspected. An indication of severity

Inhibition of proteasome activity by selected amino acids

BRL 43694: A Novel Antiemetic to Prevent Nausea and Vomiting Induced by Chemotherapy

Electrophysiologic, hemodynamic and metabolic effects of intravenous bepridil hydrochloride

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

An Overview of the Pharmacokinetics of Cilomilast (Ariflo®), a New, Orally Active Phosphodiesterase 4 Inhibitor, in Healthy Young and Elderly Volunteers

Early exercise testing and elective coronary artery bypass surgery after uncomplicated myocardial infarction. Effect on morbidity and mortality

The pharmacokinetics of doxazosin in patients with hypertension and renal impairment

Early exercise testing and coronary angiography after uncomplicated myocardial infarction

A study to compare the efficacy, plasma concentration profile and tolerability of conventional mexiletine and slow-release mexiletine

The appropriate dosage regime for the transition from intravenous lignocaine to oral tocainide after acute myocardial infarction

Nouvelles anarchistes : La création littéraire dans le presse militante (1890-1946)

Evening dosing is associated with higher plasma concentrations of pranlukast, a leukotriene receptor antagonist, in healthy male volunteers

Suchergebnisse filtern